citalopram

1
Reactions 1176 - 3 Nov 2007 S Citalopram Inappropriate antidiuretic hormone secretion: case report A 54-year-old woman, who had hypertension and was on a salt-restricted diet, developed syndrome of inappropriate secretion of antidiuretic hormone (SIADH) during treatment with citalopram. The woman, who had been on a salt-restricted diet for 6 months, started receiving citalopram 20 mg/day for worries and a depressed mood; concomitant medications included carvedilol and candesartan cilexetil. Ten days later, she reported drowsiness, paraesthesia, nausea, vomiting, visual hallucinations and fatigue and was hospitalised; Two days earlier, she had reported her symptoms to relatives and had discontinued citalopram. At presentation, she appeared euvolemic. Laboratory investigations revealed a serum sodium level of 97.4 mmol/L and a potassium level of 2.28 mmol/L. She also had serum hypo-osmolality, an elevated urine sodium level and urine hyperosmolality, which supported a diagnosis of SIADH. Psychiatric examination showed drowsiness, severe confusion, delusional thoughts, visual hallucinations and slurred speech. The woman was placed under fluid restriction and received an infusion of hypertonic saline. Six days after admission, her serum sodium level normalised and her symptoms resolved. At discharge, she had a serum sodium level of 137.2 mmol/L and a potassium level of 5.19 mmol/L. One week after discharge, she denied any symptoms and psychiatric examination only revealed an anxious mood and mildly slurred speech. Author comment: "Due to the temporal relationship between initiation of citalopram therapy and the development of SIADH as well as the exclusion of other aetiologies and return of laboratory levels to normal after discontinuation of citalopram, the most likely cause was citalopram." Bez Y, et al. Citalopram-induced SIADH in a hypertensive patient on salt restricted diet. Journal of Psychopharmacology 21: 665-667, No. 6, Aug 2007 - Turkey 801097129 1 Reactions 3 Nov 2007 No. 1176 0114-9954/10/1176-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

Upload: ngokhanh

Post on 20-Mar-2017

213 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Citalopram

Reactions 1176 - 3 Nov 2007

SCitalopram

Inappropriate antidiuretic hormone secretion: casereport

A 54-year-old woman, who had hypertension and was on asalt-restricted diet, developed syndrome of inappropriatesecretion of antidiuretic hormone (SIADH) during treatmentwith citalopram.

The woman, who had been on a salt-restricted diet for6 months, started receiving citalopram 20 mg/day for worriesand a depressed mood; concomitant medications includedcarvedilol and candesartan cilexetil. Ten days later, shereported drowsiness, paraesthesia, nausea, vomiting, visualhallucinations and fatigue and was hospitalised; Two daysearlier, she had reported her symptoms to relatives and haddiscontinued citalopram. At presentation, she appearedeuvolemic. Laboratory investigations revealed a serum sodiumlevel of 97.4 mmol/L and a potassium level of 2.28 mmol/L.She also had serum hypo-osmolality, an elevated urine sodiumlevel and urine hyperosmolality, which supported a diagnosisof SIADH. Psychiatric examination showed drowsiness, severeconfusion, delusional thoughts, visual hallucinations andslurred speech.

The woman was placed under fluid restriction and receivedan infusion of hypertonic saline. Six days after admission, herserum sodium level normalised and her symptoms resolved.At discharge, she had a serum sodium level of 137.2 mmol/Land a potassium level of 5.19 mmol/L. One week afterdischarge, she denied any symptoms and psychiatricexamination only revealed an anxious mood and mildly slurredspeech.

Author comment: "Due to the temporal relationshipbetween initiation of citalopram therapy and thedevelopment of SIADH as well as the exclusion of otheraetiologies and return of laboratory levels to normal afterdiscontinuation of citalopram, the most likely cause wascitalopram."Bez Y, et al. Citalopram-induced SIADH in a hypertensive patient on saltrestricted diet. Journal of Psychopharmacology 21: 665-667, No. 6, Aug 2007 -Turkey 801097129

1

Reactions 3 Nov 2007 No. 11760114-9954/10/1176-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved